{
    "code": "02022890",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022890",
    "time": "2020-03-06 04:04:56",
    "許可證字號": "衛署藥輸字第022890號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/05\/15",
    "發證日期": "89\/05\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202289009",
    "中文品名": "立普妥　膜衣錠20毫克",
    "英文品名": "LIPITOR FILM-COATED TABLETS 20MG",
    "適應症": "高膽固醇血症、高三酸甘油脂血症。對於臨床上沒有冠心病的第二型糖尿病患者，但是至少有任一其他冠心病危險因子，包括高血壓、視網膜病變、白蛋白尿、或吸煙，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險。降低冠心病高危險群的心血管事件發生率對於臨床上沒有冠心病的高血壓患者，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。",
    "劑型": "116膜衣錠",
    "包裝": "鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ATORVASTATIN CALCIUM (2:1) TRIHYDRATE",
    "限制項目": "02輸　入 52依本署七七公告於國內進行臨床試驗且核定為新藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0019000  PFIZER PHARMACEUTICALS LLC",
            "製造廠廠址": "KM. 1.9 ROAD 689, VEGA BAJA, PUERTO RICO 00693",
            "製造廠公司地址": "",
            "製造廠國別": "PUERTO RICO",
            "製程": "製劑廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FDE0247000  PFIZER MANUFACTURING DEUTSCHLAND GMBH",
            "製造廠廠址": "BETRIEBSSTATTE FREIBURG, MOOSWALDALLEE 1, 79090 FREIBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406003130",
            "成分名稱": "ATORVASTATIN CALCIUM (2:1) TRIHYDRATE",
            "含量描述": "eq. to 20mg Atorvastatin",
            "含量": "21.7000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "圓扁形",
        "標記一": "ATV",
        "標記二": "20"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Lipitor 20mg_20151002-104-10-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lipitor-106-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=018&Type=9"
        },
        {
            "title": "Lipitor 20mg (7)-106-11-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=012&Type=8"
        },
        {
            "title": "Lipitor 20mg (6)-106-11-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=011&Type=8"
        },
        {
            "title": "Lipitor 20mg (4)-106-11-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=010&Type=8"
        },
        {
            "title": "Lipitor 20mg (foil-new)-106-11-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022890&Seq=009&Type=8"
        }
    ]
}